Calibrate vs Hims & Hers

Vial Take

Both platforms sit in the top quartile of telehealth providers and carry clean federal records across FDA, OIG, DEA, and HIPAA, so neither raises red flags on compliance: the gap between them is about verification depth, not safety. Hims & Hers pulls ahead on every transparency signal that matters, with a 13-point trust score advantage, LegitScript certification (held by roughly 5% of providers), and a disclosed pharmacy partner, while Calibrate leaves its pharmacy, physicians, and even basic company details undisclosed, meaning you'll have fewer ways to independently confirm who's filling and overseeing your prescriptions before you sign up. If you're pursuing GLP-1 or metabolic treatment at Calibrate specifically, that supply-chain opacity is the thing worth pressure-testing first.

Biggest Differences

1. 1
   Pharmacy disclosure
   Hims & Hers publishes its compounding partner (Hims & Hers), so you can verify the supply chain; Calibrate does not name a pharmacy partner publicly.
2. 2
   LegitScript certification
   Hims & Hers holds LegitScript certification (the credential required to advertise on Google and Meta); Calibrate does not.
3. 3
   Trust Score gap (13 points)
   Hims & Hers scores 88/100 to Calibrate's 75/100, a 13-point spread driven by the differences below.